Penn Primary Care Podcast

In this podcast, Dr Williams speaks with three Penn experts on the most effective smoking cessation and alcohol reduction strategies. Dr Rachael Truchil, Dr Maggie Lowenstein, and Dr Ashish Thakrar join the program for a very practical and informative discussion. 

In this podcast, Dr Williams speaks with Dr Seniha Ozudogru and Dr Eric Kaiser of the Division of Headache and Facial Pain about the modern management of migraine and other headaches.

In this podcast, Dr Williams speaks with Dr Leslie Okorji, Surgeon at Penn, about the diagnosis and management of inguinal and abdominal hernias.

In this podcast, Dr Williams speaks with ENT surgeon Dr Robert Brody about the changing epidemiology and management of head and neck cancer and how it impacts the primary care provider.

In part 2, Dr Williams continues the discussion of the management of coronary artery disease with Dr Dan Kolansky and NP Maureen Julien, focusing on the treatment of patients with known CAD.

In this episode, Dr Williams speaks with senior cardiologist at Penn Dr Dan Kolansky and NP Maureen Julien about the contemporary management of patients with established coronary artery disease. We go over the most updated management strategies and even take a peek into the cath lab to discuss what goes on behind the curtain, and the tools we have to get a vessel open.

In this podcast, Dr Wiliams speak with thyroid expert Dr Kristen Kobaly about the workup of thyroid nodules and the initial diagnosis and treatment of thyroid cancer.

In this podcast, Dr WIlliams is joined by oncologists Dr Lynn Schucter and Dr David Porter to discuss the significant changes that have occurred in cancer therapy over the last 20 years. They highlight the new therapies that have dramatically approved the outlook for patients with various cancers and established the foundation for future advances.

In this podcast, Dr WIlliams is joined by oncologists Dr Lynn Schucter and Dr David Porter to discuss the significant changes that have occurred in cancer therapy over the last 20 years. They highlight the new therapies that have dramatically approved the outlook for patients with various cancers and established the foundation for future advances.